Niraparib, sold under the brand name Zejula, is an anti-cancer medication used for the treatment of epithelial ovarian, fallopian tube, or primary peritoneal...
16 KB (1,303 words) - 03:26, 19 June 2025
Niraparib/abiraterone acetate, sold under the brand name Akeega, is a fixed-dose combination anti-cancer medication used for the treatment of prostate...
11 KB (831 words) - 04:27, 21 April 2025
full-time employees, 59 of whom had a PhD or MD. The company's product Niraparib was granted priority review and was given a target action date of June...
5 KB (364 words) - 23:58, 12 September 2024
L01XK01 Olaparib L01XK02 Niraparib L01XK03 Rucaparib L01XK04 Talazoparib L01XK05 Veliparib L01XK06 Pamiparib L01XK52 Niraparib and abiraterone L01XL01...
13 KB (932 words) - 04:36, 23 December 2024
(Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib Niraparib +abiraterone acetate Olaparib Rucaparib) HDAC (Belinostat Entinostat Panobinostat...
4 KB (128 words) - 11:38, 22 April 2024
(Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib Niraparib +abiraterone acetate Olaparib Rucaparib) HDAC (Belinostat Entinostat Panobinostat...
5 KB (210 words) - 06:16, 5 July 2024
(Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib Niraparib +abiraterone acetate Olaparib Rucaparib) HDAC (Belinostat Entinostat Panobinostat...
19 KB (1,732 words) - 02:18, 24 June 2025
ARTooltip Androgen receptor antagonists Steroidal: Abiraterone acetate +niraparib Canrenone Chlormadinone acetate Cyproterone acetate Delmadinone acetate...
22 KB (1,748 words) - 22:20, 29 May 2025
drug pembrolizumab and PARP inhibitors, namely olaparib, rucaparib, or niraparib. Bone metastases – present in around 85% of those with metastatic prostate...
82 KB (9,187 words) - 15:44, 14 June 2025
(Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib Niraparib +abiraterone acetate Olaparib Rucaparib) HDAC (Belinostat Entinostat Panobinostat...
34 KB (3,159 words) - 04:55, 22 June 2025
ARTooltip Androgen receptor antagonists Steroidal: Abiraterone acetate +niraparib Canrenone Chlormadinone acetate Cyproterone acetate Delmadinone acetate...
12 KB (878 words) - 20:10, 29 May 2025
and gossypol. PARP inhibitors (e.g. FDA approved olaparib, rucaparib, niraparib and talazoparib) PI3K inhibitors (e.g. perifosine in a phase III trial)...
22 KB (2,364 words) - 22:18, 29 May 2025
(atovaquone) Zantac (ranitidine hydrochloride) Zeffix (lamivudine) Zejula (niraparib) Zentel (albendazole) Zinacef (cefuroxime) Zinnat (cefuroxime axetil)...
7 KB (630 words) - 14:52, 5 April 2025
ARTooltip Androgen receptor antagonists Steroidal: Abiraterone acetate +niraparib Canrenone Chlormadinone acetate Cyproterone acetate Delmadinone acetate...
27 KB (2,332 words) - 22:20, 29 May 2025
BRCA-mutant ovarian cancer. In April 2018 it was granted FDA approval. Niraparib: In March 2017 approved by US FDA for epithelial ovarian, fallopian tube...
24 KB (2,547 words) - 20:33, 9 June 2025
(Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib Niraparib +abiraterone acetate Olaparib Rucaparib) HDAC (Belinostat Entinostat Panobinostat...
13 KB (842 words) - 22:19, 29 May 2025
(Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib Niraparib +abiraterone acetate Olaparib Rucaparib) HDAC (Belinostat Entinostat Panobinostat...
27 KB (2,339 words) - 21:12, 29 May 2025
ARTooltip Androgen receptor antagonists Steroidal: Abiraterone acetate +niraparib Canrenone Chlormadinone acetate Cyproterone acetate Delmadinone acetate...
36 KB (3,348 words) - 03:08, 20 June 2025
ARTooltip Androgen receptor antagonists Steroidal: Abiraterone acetate +niraparib Canrenone Chlormadinone acetate Cyproterone acetate Delmadinone acetate...
191 KB (18,328 words) - 22:14, 29 May 2025
ARTooltip Androgen receptor antagonists Steroidal: Abiraterone acetate +niraparib Canrenone Chlormadinone acetate Cyproterone acetate Delmadinone acetate...
43 KB (3,691 words) - 08:28, 18 June 2025
(Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib Niraparib +abiraterone acetate Olaparib Rucaparib) HDAC (Belinostat Entinostat Panobinostat...
40 KB (3,616 words) - 12:21, 23 May 2025
ARTooltip Androgen receptor antagonists Steroidal: Abiraterone acetate +niraparib Canrenone Chlormadinone acetate Cyproterone acetate Delmadinone acetate...
25 KB (2,033 words) - 20:48, 16 June 2025
ARTooltip Androgen receptor antagonists Steroidal: Abiraterone acetate +niraparib Canrenone Chlormadinone acetate Cyproterone acetate Delmadinone acetate...
4 KB (257 words) - 17:50, 11 November 2023
(Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib Niraparib +abiraterone acetate Olaparib Rucaparib) HDAC (Belinostat Entinostat Panobinostat...
21 KB (1,824 words) - 12:17, 23 June 2025
ARTooltip Androgen receptor antagonists Steroidal: Abiraterone acetate +niraparib Canrenone Chlormadinone acetate Cyproterone acetate Delmadinone acetate...
62 KB (5,616 words) - 02:28, 2 June 2025
found to increase sensitivity to PARP inhibitors, such as olaparib and niraparib, offering new treatment avenues. Research into various prognostic factors...
199 KB (21,290 words) - 19:03, 13 June 2025
ARTooltip Androgen receptor antagonists Steroidal: Abiraterone acetate +niraparib Canrenone Chlormadinone acetate Cyproterone acetate Delmadinone acetate...
161 KB (15,261 words) - 19:58, 29 May 2025
ARTooltip Androgen receptor antagonists Steroidal: Abiraterone acetate +niraparib Canrenone Chlormadinone acetate Cyproterone acetate Delmadinone acetate...
19 KB (1,557 words) - 08:27, 18 June 2025
(Anagrelide) IMPDI (Tiazofurin§) LI (Masoprocol) PARP inhibitor (Fuzuloparib Niraparib +abiraterone acetate Olaparib Rucaparib) HDAC (Belinostat Entinostat Panobinostat...
25 KB (2,171 words) - 20:01, 29 May 2025
ARTooltip Androgen receptor antagonists Steroidal: Abiraterone acetate +niraparib Canrenone Chlormadinone acetate Cyproterone acetate Delmadinone acetate...
49 KB (4,675 words) - 21:46, 29 May 2025